The ROC analysis revealed that TRPV2/5/6 had a high performance for distinguishing ccRCC patients from healthy individuals (AUC>0.9), suggesting that TRPV2/5/6 might serve as a diagnostic biomarker for patients with ccRCC. The gene discussed is TRPV2; the disease is nonpapillary renal cell carcinoma.